These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32790488)

  • 1. A Geroscience Approach to Preventing Pathologic Consequences of COVID-19.
    Dou Y; Fatemi S; Darvas M; Gale M; Ladiges W
    J Interferon Cytokine Res; 2020 Sep; 40(9):433-437. PubMed ID: 32790488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
    Hajivalili M; Hosseini M; Haji-Fatahaliha M
    Life Sci; 2020 Sep; 257():118058. PubMed ID: 32653518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Geroscience Perspective on COVID-19 Mortality.
    Promislow DEL
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):e30-e33. PubMed ID: 32300796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.
    Wu D; Yang XO
    J Microbiol Immunol Infect; 2020 Jun; 53(3):368-370. PubMed ID: 32205092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we unstress SARS-CoV-2 infected cells?
    Csukasi F; Rico G; Becerra J; Duran I
    Cytokine Growth Factor Rev; 2020 Aug; 54():3-5. PubMed ID: 32563554
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19.
    Husain A; Byrareddy SN
    Chem Biol Interact; 2020 Nov; 331():109282. PubMed ID: 33031791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First motor seizure as presenting symptom of SARS-CoV-2 infection.
    Fasano A; Cavallieri F; Canali E; Valzania F
    Neurol Sci; 2020 Jul; 41(7):1651-1653. PubMed ID: 32417987
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.
    Dashraath P; Wong JLJ; Lim MXK; Lim LM; Li S; Biswas A; Choolani M; Mattar C; Su LL
    Am J Obstet Gynecol; 2020 Jun; 222(6):521-531. PubMed ID: 32217113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    Costiniuk CT; Jenabian MA
    Cytokine Growth Factor Rev; 2020 Jun; 53():63-65. PubMed ID: 32467020
    [No Abstract]   [Full Text] [Related]  

  • 10. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
    Lupu L; Palmer A; Huber-Lang M
    Front Immunol; 2020; 11():584514. PubMed ID: 33101314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audio Interview: Acute Lung Injury in Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jul; 383(2):e32. PubMed ID: 32640146
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
    Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R
    Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.
    Vallamkondu J; John A; Wani WY; Ramadevi SP; Jella KK; Reddy PH; Kandimalla R
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165889. PubMed ID: 32603829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consideration of Pannexin 1 channels in COVID-19 pathology and treatment.
    Swayne LA; Johnstone SR; Ng CS; Sanchez-Arias JC; Good ME; Penuela S; Lohman AW; Wolpe AG; Laubach VE; Koval M; Isakson BE
    Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L121-L125. PubMed ID: 32519892
    [No Abstract]   [Full Text] [Related]  

  • 17. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
    McGowan EM; Haddadi N; Nassif NT; Lin Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocilizumab in the treatment of a critical COVID-19 patient: a case report.
    Wang L; Peng X; Wang ZH; Cai J; Zhou FC
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5783-5787. PubMed ID: 32495916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
    Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
    Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.